DeepPrecisionOnco is a deep learning-based technology that processes single-cell and bulk RNA sequencing data to construct detailed maps of cellular states and signaling in the tumor microenvironment. It harnesses advanced modeling techniques such as deep belief networks, Boltzmann machines, and topic modeling to analyze thousands of gene expression signals—including somatic mutations, transcription factor activity, and immune cell activation. This technique simulates hierarchical cell signaling processes, enabling the precise identification of cancer pathways and tumor-specific aberrations while predicting individual patient responses to therapies.
Description
What sets this approach apart is its focus on modeling the interplay between tumor and immune cells, rather than relying solely on mutation profiles. It distinguishes itself by integrating data from both tumor and immune cell populations to capture the heterogeneity of the tumor microenvironment. This comprehensive view allows for unique insights into immune cell behavior—particularly that of T-cells affecting tumor-immune crosstalk—thus facilitating more personalized predictions of immunotherapy outcomes and overall drug response.
Applications
- Personalized cancer treatment
- Predict immunotherapy response
- Optimize drug selection
- Tumor microenvironment profiling
Advantages
- Accurate modeling of the intricate tumor-immune cell interactions to identify key cancer signaling pathways.
- Enhanced prediction of patient-specific responses to immunotherapy and other targeted treatments.
- Integration of both single-cell and bulk RNA sequencing data for a comprehensive view of cellular heterogeneity.
- Detection of tumor-specific aberrations, providing insights for personalized drug selection and treatment strategies.
- Utilization of advanced deep learning approaches to reflect dynamic, hierarchical cellular signaling in the tumor microenvironment.
IP Status
Copyright
